Article
SHP-2 and myeloid malignancies.
Current opinion in hematology - 1 Jan 2004
Tartaglia Marco, Niemeyer Charlotte M, Shannon Kevin M, Loh Mignon L
Abstract excerpt
PURPOSE OF REVIEW: This review focuses on the non-receptor Src-homology 2 domain-containing protein tyrosine phosphatase SHP-2 and its role in signal transduction, hematopoiesis, and leukemogenesis. Specifically, we discuss the role of inherited and somatic mutations that result in SHP-2 gain-of-function in human disease, including myeloid malignancies. RECENT FINDINGS: Up-regulation of RAS signaling is a major...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
